Zinzino October Revenue Rises 1% to 328.7 Million Kronor as North America Jumps 46%

GOTHENBURG, Sweden - November 4, 2026

Zinzino reported preliminary group revenue of 328.7 million Swedish kronor for October, up 1 percent from 326.0 million kronor a year earlier, as growth in North America, South America, and Asia-Pacific offset declines across several European regions.

Revenue from Zinzino's sales markets rose 1 percent to 325.1 million kronor from 323.3 million kronor. External sales at the company's Faun Pharma manufacturing unit increased 33 percent to 3.6 million kronor from 2.7 million kronor.

Accumulated revenue for January through October increased 19 percent to 3,128.0 million kronor from 2,628.2 million kronor.

By region in October, North America was the largest growth driver, climbing 46 percent to 72.2 million kronor from 49.5 million kronor. South America rose 87 percent to 2.8 million kronor, and Asia-Pacific increased 17 percent to 32.3 million kronor. Central Europe, the company's largest region in the month at 101.6 million kronor, was up 1 percent.

European weakness weighed on the monthly comparison. The Nordics fell 20 percent to 29.4 million kronor, East Europe dropped 24 percent to 26.3 million kronor, South and West Europe declined 13 percent to 49.6 million kronor, and the Baltics fell 33 percent to 8.7 million kronor. Africa slipped 4 percent to 2.2 million kronor.

On a year-to-date basis through October, North America remained the standout, up 59 percent to 672.0 million kronor. South America increased 268 percent to 35.7 million kronor, and Central Europe rose 26 percent to 951.7 million kronor. East Europe was down 13 percent, the Baltics were down 8 percent, and the Nordics were down 2 percent. Sales-market revenue for the first ten months reached 3,078.1 million kronor, up 19 percent, while Faun Pharma's external sales were up 16 percent to 49.9 million kronor.

The flash report covers sales by region and does not include profit figures. Zinzino, based in Gothenburg, Sweden, is listed on Nasdaq First North Premier Growth Market and sells test-based nutrition products through direct sales distributors in more than 100 markets.